Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

177.72
Delayed Data
As of Oct 17
 +1.63 / +0.93%
Today’s Change
151.80
Today|||52-Week Range
195.81
+7.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues1.0B1.7B2.5B3.0B
 
 
 
 
 
Cost of Goods Sold62.2M149.1M213.7M337.1M
 
 
 
 
 
Depreciation And Amortization62.3M61.4M61.4M72.4M
 
 
 
 
 
 
Operating ExpensesGross Income907.8M1.5B2.2B2.6B
 
 
 
 
 
General Expenses1.4B1.5B1.8B2.0B
 
 
 
 
 
Research And Development995.9M1.0B1.3B1.4B
 
 
 
 
 
Total Operating Expenses1.5B1.7B2.1B2.4B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-464.7M11.2M397.9M665.2M
 
 
 
 
 
Extraordinary Credit0.000.000.00807.0K
 
 
Extraordinary Charge-2.2M-1.3M-288.8M-29.0M
 
 
 
 
 
Interest Expense On Debt84.2M81.4M57.6M34.1M
 
 
 
 
 
Other Expenses-6.7M4.1M-67.3M-2.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-557.8M-67.4M-15.7M600.2M
 
 
 
 
 
Income Taxes-30.4M-16.7M-107.3M-1.5B
 
 
 
 
 
Minority Interest-31.8M-28.0M-171.8M-9.8M
 
 
 
 
 
Net Income-556.3M-112.1M263.2M2.1B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS241.3M244.7M248.9M254.3M
 
 
 
 
 
Shares To Calculate EPS Diluted241.3M244.7M253.2M259.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.31-$0.46$1.04$8.09
 
 
 
 
 
EPS Diluted-$2.31-$0.46$1.04$8.09